The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C
| Image |  |
|---|---|
| Description | scientific article published on 30 December 2010 |
| Author/s |
author: Matthew Links Peter Galettis |
| Publication date | December 30, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |